Jefferson Site-based Clinical Research Group

Rheumatology

Lupus

Principle Investigator: Oscar Irigoyen, MD

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Patients with Systemic Lupus Erythematosus (SLE)

Links

CURRENT STUDIES

Therapeutic Areas

General Cardiology
Heart Failure
Infectious Disease
Interventional Cardiology
Pulmonary
Rheumatology
Vascular

ClinicalTrials.gov

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement